Abang, Rashfek D.

HRN: 21-79-00  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
CEFUROXIME 750MG (VIAL)
11/29/2022
12/05/2022
IV
450mg
Q8Hrs
AGE With Mod Dehydration; Covid-19 Pneumonia Mild
Waiting Final Action 
11/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2022
12/05/2022
IV
150mg
Q8Hrs
AGE With Mod Dehydration; Covid-19 Pneumonia Mild
Waiting Final Action 
09/27/2023
CEFTRIAXONE 1G (VIAL)
09/27/2023
10/03/2023
IVT
620mg
Q12
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: